meglumine has been researched along with Adverse Drug Event in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho, AG; Carvalho, CDP; Carvalho, RDP; Dias, JVL; Luz, JGG; Pires, HHR | 1 |
| Alves, FP; Amaral, TA; Costa, CHN; Costa, DL; de Almeida, RP; de Carvalho, AL; de Carvalho, SFG; de Melo, EV; Leite, RD; Lima, SS; Rabello, A; Rode, J; Romero, GAS; Sousa, AQ | 1 |
| Andrade, PHS; da Silva, WB; Lobo, IMF | 1 |
| Abu Alfa, AK; Bauer, K; Belknap, SM; Bhatt, K; Bull, C; Cowper, SE; Edwards, BJ; Fisher, MJ; Hammel, JA; Kanal, E; Laumann, AE; McKoy, JM; Miller, FH; Nardone, B; Raisch, DW; Restaino, J; Saddleton, E; Samaras, AT; Thomsen, HS; West, DP | 1 |
| Alhilali, L; Fakhran, S; Kale, H; Kanal, E | 1 |
| Azeredo-Coutinho, RB; Baptista, C; Conceição-Silva, F; de Almeida Marzochi, MC; de Camargo Ferreira E Vasconcellos, E; de Fátima Madeira, M; de Matos Salgueiro, M; de Oliveira Schubach, A; de Souza Coutinho, R; Fernandes Pimentel, MI; Pereira Quintella, L; Roberto Mortari, S; Rosandiski Lyra, M; Soares Moreira, J; Valete-Rosalino, CM | 1 |
| Dagaev, SG; Kovalenko, AL; Lesiovskaia, EE; Petrov, AIu; Savateev, AV; Savateeva-Liubimova, TN; Shevchuk, MK; Sivak, KV; Stosman, KI; Sukhanov, DS | 1 |
| Durmus, T; Hamm, B; Heine, O; Maurer, M; Wagner, M; Wolf, M | 1 |
| Bücker, A; Fries, P; Kirchin, MA; Schneider, G; Schürholz, H | 1 |
1 trial(s) available for meglumine and Adverse Drug Event
| Article | Year |
|---|---|
Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial.
Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome; Young Adult | 2017 |
8 other study(ies) available for meglumine and Adverse Drug Event
| Article | Year |
|---|---|
"It's not all about the disease": do treatment and socioeconomic status affect perceived impact and satisfaction of patients treated for cutaneous leishmaniasis?
Topics: Antiprotozoal Agents; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Satisfaction; Social Class | 2023 |
Risk factors for adverse drug reactions in pediatric inpatients: A cohort study.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Anesthesia, General; Anti-Bacterial Agents; Anticonvulsants; Brazil; Child; Child, Preschool; Clonazepam; Cohort Studies; Cystic Fibrosis; Dipyrone; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Diseases; Hospitalization; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Inpatients; Male; Meglumine; Omeprazole; Pediatrics; Pilot Projects; Proportional Hazards Models; Regression Analysis; Risk Factors | 2017 |
Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.
Topics: Contrast Media; Cooperative Behavior; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Male; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Pharmacovigilance; Registries; United States | 2014 |
Assessment of rates of acute adverse reactions to gadobenate dimeglumine: review of more than 130,000 administrations in 7.5 years.
Topics: Contrast Media; Drug-Related Side Effects and Adverse Reactions; Humans; Incidence; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pennsylvania; Prospective Studies; Quality Assurance, Health Care; Risk Assessment; Risk Factors | 2015 |
American tegumentary leishmaniasis in older adults: 44 cases treated with an intermittent low-dose antimonial schedule in Rio de Janeiro, Brazil.
Topics: Age Factors; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2010 |
[Preclinical study of Reamberin and Remaxol safety].
Topics: Animals; Dogs; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Female; Male; Meglumine; Rats; Shock; Succinates | 2010 |
Tolerability and diagnostic value of gadoteric acid in the general population and in patients with risk factors: results in more than 84,000 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Comorbidity; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Germany; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nausea; Organometallic Compounds; Prevalence; Risk Assessment; Risk Factors; Urticaria; Vomiting; Young Adult | 2012 |
Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Germany; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Prevalence; Risk Factors | 2013 |